Compare THS & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | THS | CNTA |
|---|---|---|
| Founded | 2021 | 2020 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 2.3B |
| IPO Year | N/A | 2021 |
| Metric | THS | CNTA |
|---|---|---|
| Price | $23.66 | $24.77 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 7 | 11 |
| Target Price | $24.67 | ★ $37.70 |
| AVG Volume (30 Days) | 772.1K | ★ 1.5M |
| Earning Date | 11-10-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,336,000,000.00 | $15,000,000.00 |
| Revenue This Year | $1.43 | N/A |
| Revenue Next Year | $0.71 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 118.88 |
| 52 Week Low | $15.85 | $9.60 |
| 52 Week High | $40.77 | $30.58 |
| Indicator | THS | CNTA |
|---|---|---|
| Relative Strength Index (RSI) | 58.22 | 38.02 |
| Support Level | $23.76 | $25.59 |
| Resistance Level | $24.02 | $30.02 |
| Average True Range (ATR) | 0.23 | 1.29 |
| MACD | -0.16 | -0.67 |
| Stochastic Oscillator | 17.80 | 10.14 |
TreeHouse Foods is the largest pure-play private-label manufacturer in the US. Much larger in the past following the 2016 acquisition of Ralcorp, Conagra's former private-label business, the company has since divested several businesses to focus on high-growth categories. At present, the company produces and sells snacks (crackers, pretzels, cookies, and so on), beverages (such as nondairy creamer, coffee, tea, broth), and a select number of grocery products (pickles, refrigerated dough, hot cereal, cheese, and pudding). Its most important sales channel is through retail grocery stores that sell its products under their own brands, with co-manufacturing and food away from home as much smaller channels of distribution for its fare.
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.